The high methylation level of a novel 151-bp CpG island in the ESR1 gene promoter is associated with a poor breast cancer prognosis
Laura Itzel Quintas‐Granados(El Colegio Mexiquense), Octavio D. Reyes‐Hernández(Universidad Nacional Autónoma de México)
Cited by 10
Related Papers
Epigenetic dysregulation in cancer: mechanisms, diagnostic biomarkers and therapeutic strategies
|Medical Oncology|2025|10